ASX:1ST

1st Group Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume1.33 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

1st Group (ASX:1ST) Vs. ALC, BNVIF, CNNA, CNONF, DOCRF, and DOC

Should you be buying 1ST stock or one of its competitors? Companies in the industry of "health information services" are considered alternatives and competitors to 1st Group, including Alcidion Group (ALC), Binovi Technologies (BNVIF), Cann American (CNNA), CannaOne Technologies (CNONF), CloudMD Software & Services (DOCRF), and CloudMD Software & Services (DOC).

Alcidion Group (ASX:ALC) and 1st Group (ASX:1ST) are both computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership and dividends.

Profitability

This table compares Alcidion Group and 1st Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Alcidion GroupN/AN/AN/A
1st GroupN/AN/AN/A

Earnings and Valuation

This table compares Alcidion Group and 1st Group's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alcidion Group$21.55 million0.00$-2,972,082.05A$0.00N/A
1st Group$5.11 million0.00$-4,246,169.92A($0.01)N/A

Alcidion Group has higher revenue and earnings than 1st Group.

Analyst Ratings

This is a summary of current ratings and target prices for Alcidion Group and 1st Group, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Alcidion Group0000N/A
1st Group0000N/A

Summary

Alcidion Group beats 1st Group on 3 of the 3 factors compared between the two stocks.

1st Group (ASX:1ST) and Binovi Technologies (OTCMKTS:BNVIF) are both computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, earnings, dividends and analyst recommendations.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for 1st Group and Binovi Technologies, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
1st Group0000N/A
Binovi Technologies0000N/A

Profitability

This table compares 1st Group and Binovi Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
1st GroupN/AN/AN/A
Binovi TechnologiesN/AN/AN/A

Earnings and Valuation

This table compares 1st Group and Binovi Technologies' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
1st Group$5.11 million0.00$-4,246,169.92A($0.01)N/A
Binovi TechnologiesN/AN/AN/AN/AN/A

Binovi Technologies has lower revenue, but higher earnings than 1st Group.

Summary

1st Group beats Binovi Technologies on 1 of the 1 factors compared between the two stocks.

1st Group (ASX:1ST) and Cann American (CNSX:CNNA) are both computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, earnings, dividends and analyst recommendations.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for 1st Group and Cann American, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
1st Group0000N/A
Cann American0000N/A

Profitability

This table compares 1st Group and Cann American's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
1st GroupN/AN/AN/A
Cann AmericanN/AN/AN/A

Earnings and Valuation

This table compares 1st Group and Cann American's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
1st Group$5.11 million0.00$-4,246,169.92A($0.01)N/A
Cann AmericanN/AN/AN/AN/AN/A

Cann American has lower revenue, but higher earnings than 1st Group.

Summary

1st Group beats Cann American on 1 of the 1 factors compared between the two stocks.

1st Group (ASX:1ST) and CannaOne Technologies (OTCMKTS:CNONF) are both computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, earnings, dividends and analyst recommendations.

Profitability

This table compares 1st Group and CannaOne Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
1st GroupN/AN/AN/A
CannaOne TechnologiesN/AN/AN/A

Earnings and Valuation

This table compares 1st Group and CannaOne Technologies' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
1st Group$5.11 million0.00$-4,246,169.92A($0.01)N/A
CannaOne TechnologiesN/AN/AN/AN/AN/A

CannaOne Technologies has lower revenue, but higher earnings than 1st Group.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for 1st Group and CannaOne Technologies, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
1st Group0000N/A
CannaOne Technologies0000N/A

Summary

1st Group beats CannaOne Technologies on 1 of the 1 factors compared between the two stocks.

CloudMD Software & Services (OTCMKTS:DOCRF) and 1st Group (ASX:1ST) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, profitability, dividends, institutional ownership, risk and earnings.

Profitability

This table compares CloudMD Software & Services and 1st Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CloudMD Software & ServicesN/AN/AN/A
1st GroupN/AN/AN/A

Earnings and Valuation

This table compares CloudMD Software & Services and 1st Group's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CloudMD Software & ServicesN/AN/AN/AN/AN/A
1st Group$5.11 million0.00$-4,246,169.92A($0.01)N/A

CloudMD Software & Services has higher earnings, but lower revenue than 1st Group.

Analyst Ratings

This is a summary of current recommendations and price targets for CloudMD Software & Services and 1st Group, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CloudMD Software & Services00203.00
1st Group0000N/A

CloudMD Software & Services presently has a consensus target price of $3.3750, suggesting a potential upside of 103.31%.

CloudMD Software & Services (CVE:DOC) and 1st Group (ASX:1ST) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, profitability, risk, analyst recommendations and dividends.

Valuation & Earnings

This table compares CloudMD Software & Services and 1st Group's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CloudMD Software & ServicesC$11.65 million35.32$-17,801,550.00C($0.09)-23.11
1st Group$5.11 million0.00$-4,246,169.92A($0.01)N/A

1st Group has lower revenue, but higher earnings than CloudMD Software & Services. CloudMD Software & Services is trading at a lower price-to-earnings ratio than 1st Group, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of current ratings for CloudMD Software & Services and 1st Group, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CloudMD Software & Services01102.50
1st Group0000N/A

CloudMD Software & Services currently has a consensus target price of C$3.88, suggesting a potential upside of 86.30%.

Profitability

This table compares CloudMD Software & Services and 1st Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CloudMD Software & ServicesN/AN/AN/A
1st GroupN/AN/AN/A


1st Group Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
ALC
Alcidion Group
0.5N/AN/A$0.00$21.55 million0.00High Trading Volume
News Coverage
Gap Up
Binovi Technologies logo
BNVIF
Binovi Technologies
0.0$0.06flat$0.00N/A0.00Decrease in Short Interest
Gap Down
CNNA
Cann American
0.5N/AN/A$0.00N/A0.00High Trading Volume
CannaOne Technologies logo
CNONF
CannaOne Technologies
0.6$0.98flat$0.00N/A0.00Decrease in Short Interest
CloudMD Software & Services logo
DOCRF
CloudMD Software & Services
1.7$1.66flat$0.00N/A0.00Decrease in Short Interest
DOC
CloudMD Software & Services
1.2$2.08flatC$0.00C$11.65 million-23.11
CGS
Cogstate
0.5N/AN/A$0.00$28.82 million0.00High Trading Volume
Gap Up
COO
Corum Group
0.5N/AN/A$0.00$12.27 million0.00High Trading Volume
EGF Theramed Health logo
EVAHF
EGF Theramed Health
0.0$0.11flat$0.00N/A0.00Decrease in Short Interest
News Coverage
Gap Down
EMD
Emyria
0.6N/AN/A$0.00$1.73 million0.00High Trading Volume
Gap Up
EWLL
eWellness Healthcare
0.6$0.00flat$0.00N/A0.00
FORA
Forian
0.3$12.11flat$0.00N/A0.00High Trading Volume
GLH
Global Health
0.5N/AN/A$0.00$6.77 million0.00High Trading Volume
Gap Up
ICS
ICS Global
0.9N/AN/A$0.00$6.08 million0.00High Trading Volume
Gap Up
JHL
Jayex Healthcare
0.7N/AN/A$0.00$6.61 million0.00High Trading Volume
Gap Up
M3 logo
MTHRF
M3
1.0$76.00flat$0.00N/A0.00
M7T
Mach7 Technologies
0.6N/AN/A$0.00$16.89 million0.00High Trading Volume
Gap Up
MDR
MedAdvisor
0.5N/AN/A$0.00$18.09 million0.00High Trading Volume
Gap Up
NEWUF
Newtopia
1.7$0.41flat$0.00N/A0.00Gap Up
NHL
Novita Healthcare
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
ONE
Oneview Healthcare
0.5N/AN/A$0.00$7.10 million0.00High Trading Volume
OPL
Opyl
0.0N/AN/A$0.00$741,494.000.00High Trading Volume
PCK
PainChek
0.0N/AN/A$0.00$240,424.000.00High Trading Volume
PANHF
Ping An Healthcare and Technology
1.0$12.20flat$0.00N/A0.00Gap Up
PKS
PKS
0.0N/AN/A$0.00$5.97 million0.00High Trading Volume
PME
Pro Medicus
0.7N/AN/A$0.00$59.12 million0.00High Trading Volume
Gap Up
Pro Medicus logo
PMCUF
Pro Medicus
0.5$35.65flat$0.00N/A0.00Decrease in Short Interest
RAP
ResApp Health
0.9N/AN/A$0.00$46,197.000.00High Trading Volume
Gap Up
CBIIF
Skylight Health Group
0.0$0.95flat$0.00N/A0.00News Coverage
TD1
TALi Digital
0.5N/AN/A$0.00$706,550.000.00High Trading Volume
UCBB
US-China Biomedical Technology
0.3$0.13flat$0.00N/A0.00
WELL Health Technologies logo
WLYYF
WELL Health Technologies
1.6$6.00flat$0.00N/A0.00
ZMD
ZoomMed
0.4$0.02flatC$0.00C$10,000.00-1.36Gap Down
This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.